Form 8-K - Current report:
SEC Accession No. 0001625297-25-000025
Filing Date
2025-03-27
Accepted
2025-03-27 16:19:36
Documents
18
Period of Report
2025-03-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K indv-20250327.htm   iXBRL 8-K 42233
2 EX-99.1 ex991rns-publicationof2025.htm EX-99.1 5505
3 EX-99.2 ex992boardchairletter.htm EX-99.2 11520
4 EX-99.3 ex993compcommchairsletter.htm EX-99.3 15437
8 image_0a.jpg GRAPHIC 168866
9 image_1a.jpg GRAPHIC 117
  Complete submission text file 0001625297-25-000025.txt   442369

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT indv-20250327.xsd EX-101.SCH 1773
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT indv-20250327_lab.xml EX-101.LAB 21615
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT indv-20250327_pre.xml EX-101.PRE 12502
20 EXTRACTED XBRL INSTANCE DOCUMENT indv-20250327_htm.xml XML 2737
Mailing Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE
Business Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE 804-379-1090
INDIVIOR PLC (Filer) CIK: 0001625297 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37835 | Film No.: 25779566
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)